RE:Next Set of Quarterly FinancialsStellar results. I'm going to hold you to that because that is straight up pumping off something you wouldn't have any tangible information about. Personally I think they are going to be terrible but that is an opinion not a certainty like the way you phrased stellar results. The acquisitions should bring in a large shareholder deficit due to marginal "instantaneous revenue" and zero revenue for Add Biomedical. Average testing numbers based on previous news releases also that won't get close to a break even from the liabilities.
But don't worry. My gut says name change and marketing launch immediately to mask the odor of the timid results